Business & Industry

Bavarian Nordic, the vaccine maker, on July 28 said that it has agreed in principle for roughly $3 bn take-private offer from private equity firms Permira and Nordic Capital. Apparently, the board of directors of the company plan to unanimously...

The biopharmaceutical sector of South Korea has seen a growth in innovators and drug licensing agreements by way of reaching a total deal value of almost $8 billion in 2025 year-to-date. It has emerged as a biopharma innovation hub...

Finally, the Trump administration’s much-animated tariffs on pharmaceutical imports are now materializing in a new EU-US trade deal. However, there are still many questions that remain. As part of a trade agreement that was reached between the US and the...

AstraZeneca announces $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines manufacturing and R&D. This investment is expected to create tens of thousands of new, highly skilled direct and indirect jobs...

LaNova Medicines, which happens to be a cancer drugmaker that previously licensed medicines to AstraZeneca as well as Merck & Co., has gone on to agree to get acquired by Sino BioPharmaceuticals in a deal worth almost $951 million. In...

The pharmaceutical business has a major economic influence on both local and worldwide markets, and it is always changing according to different market trends. Packaging is essential to this industry. At the moment, the packaging guarantees patient safety by offering...

It is well to be noted that the pharmaceutical sector has for long been characterized by its intricate, global supply chains designed in order to optimize production, decrease costs, and make sure that there is a timely delivery of...